Pharmaceutical Intermediates Market
Market Insights on Pharmaceutical Intermediates covering sales outlook, demand forecast & up-to-date key trends
Pharmaceutical Intermediates Market by Product (Chemical Intermediates, Bulk Drug Intermediates, Custom Intermediates), Category (Branded Drug Intermediates, Generic Drug Intermediates), Application, End User & Region - Forecast to 2020-2030
Pharmaceutical Intermediates Market - About the Report
[296 Pages Report] Pharmaceutical intermediates are used as raw materials during the manufacture of bulk drugs. Leading biopharmaceutical and pharmaceutical manufacturing companies are focusing on improving their product footprint globally. These companies are focusing on strengthening their product reach in different countries across the world through various distribution channels. Growth outlook therefore remains positive for pharmaceutical intermediates market as companies continue focusing on enhancing the capacities of their manufacturing plants in various countries of the world.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors fuelling demand for pharmaceutical intermediates. The report tracks the global sales of pharmaceutical intermediates in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the pharmaceutical industry in general and the market in particular.
Let us know your requirement to get
100% FREE customization
Pharmaceutical Intermediates Market - Historical and Future Outlook
The rapidly increasing prevalence of chronic diseases and growth of the aging population across the world are among factors that are expected to increase the need for drug formulations for the prevention of chronic diseases. For instance, as per the International Diabetes Federation Diabetes, The global diabetes prevalence in 2019 is estimated to be 9.3% (463 million people), rising to 10.2% (578 million) by 2030, and the number is rising rapidly. Pharmaceutical drugs have remained key to management of chronic diseases and other diseases.
For instance, according to the World Health Organization (WHO), the prevalence of chronic diseases is expected to increase by 57.0% by 2020, which indicates that a significant percentage of population is suffering from chronic diseases. According to FMI’s analysis, pharmaceutical intermediates sales have grown at 3.7% CAGR between 2015 and 2019.
Various small- and medium-scale companies are also focusing on enhancing their production capacity, which is another factor that is expected to fuel growth of the pharmaceutical intermediates demand. Hence demand for pharmaceutical intermediate is increasing and sales are set to grow significantly through 2030.
Moreover, major pharma companies are increasingly relying on contract manufacturing organizations for the manufacturing of pharmaceutical intermediates and final formulations. These companies are focusing on enhancing the capacities of their manufacturing plants in various countries of the world, such as India and China, where the cost of production is comparatively lower. These developments present a positive outlook for growth. FMI expects global pharmaceutical intermediates market to grow at 4.3% CAGR through 2030.
How is Prevalence of Chronic Ailments Aiding Growth?
The rapidly increasing prevalence of chronic diseases and rising the aging population across the world are among chief factors that are expected to increase the need for drug formulations for the prevention of various diseases. According to the World Health Organization (WHO), population comprising of people aged 60 years and above is expected to total 2 billion by 2050. Also, according to the WHO, diabetes continues to be a major cause of kidney failure, stroke, heart attacks, and other chronic ailments.
Moreover, the global increase in aging population is expected to increase the demand for drugs for the management of age-related chronic conditions, which is also expected to boost the pharmaceutical intermediates market. Outbreak of pandemics such as COVID-19, H1N1, Ebola, and others are increasing the requirement of different pharmaceutical intermediates as well as APIs, which signifies the growth potential for the pharmaceutical intermediates.
As a matter of fact the demand for generic and branded products is on rise due to the prevalence of various chronic diseases and increasing aging population, which in turn, is expected to create significant revenue generation opportunities for the pharmaceutical intermediates market. Manufacturers of API are also trying to enhance their production due to the high global demand owing to a shortage of various generic drugs. Increasing reach of various pharma players in the developing countries is also expected to boost the demand for pharmaceutical intermediates.
The WHO has launched Integrated Chronic Disease Prevention and Control Programme (ICP), which is one of the leading technical programme within the Department of Chronic Diseases and Health Promotion (CHP). Such initiatives are expected to support overall expansion of the market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow is Drug Development Aiding Growth?
Due to rapid development happening in the biotechnology and life science field, demand registered in the market has been significantly rising. Moreover, a wide array of application and increasing adoption of pharmaceutical intermediates in the field of clinical research are creating lucrative prospects for growth. Manufacturers in the biotechnology and pharmaceutical sectors are focusing on drug development activities along with research institutes, especially in the wake of COVID-19.
In fact the ongoing pandemic has been reshaping the pharmaceutical supply chain. Chemical and Engineering news had reported in April 2020, that Director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, Janet Woodcock, has shared with a House of Representatives subcommittee that the number of facilities in China supplies active pharmaceutical ingredients has more than doubled itself since 2010. This is presents positive outlook for the market.
Pharmaceutical Intermediates Market - Country-wise Insights
How is China Contributing as Key Supplier of Pharmaceutical Intermediates?
FMI has projected East Asia hold more than thirty percent markets share through the course of the forecast period. Growth within the region is likely to be spearheaded by China. As per FMI, the China pharmaceutical intermediates market is estimated to surpass US$ 7 Bn in 2021, exhibiting a CAGR of 6% through 2030.
China remains one of the largest markets for pharmaceutical industries in the world. The China Government has been supporting research and development initiatives by various pharmaceutical companies with special attention to the biotechnology sector. Moreover, government taking initiative to support for foreign investment in R&D. providing better access of medicine to people is the prime concern for the Chinese Government.
Pharmaceuticals account for a substantial part of the current China health care budget. According to China.org.cn, China’s pharmaceutical market is expected to reach US$161.8 bn by 2023. Also as per, the Information Technology and Innovation Foundation, the 2017 Biopharmaceutical Competitiveness and Investment Survey has ranked China 20th among 27 nations on a variety of measures undertaken for biopharma innovation.
Chinese pharmaceutical manufacturers have until recently concentrated on the production of basic chemicals, intermediates and APIs. In short period of time, China has become the leading global supplier of APIs in terms of volume. As per the WHO report, in 2017 “Total revenues from sales of pharmaceuticals in China are substantially in excess of 100 billion US$, making China the second-largest pharmaceutical market in the world”
Heavy Investment by Manufacture Strengthening U.S. Market
Leading pharmaceutical companies have announced their intentions to invest in manufacturing facilities due to various reasons such as enhancing the production capacity, reducing corporate tax rate in the U.S., among others. The recent tax reforms in the country which include reduction of the corporate tax rate, have encouraged various large biopharmaceutical and pharmaceutical companies to invest in production facilities.
For example, in July 2018, Pfizer announced its plan to invest around US$ 465.0 million to build a sterile injectable plant in Portage, Michigan. This step is a part of its announcement that it had made earlier in 2018 about its plans to invest around US$ 5.0 billion in a U.S.-based capital project due to the recent corporate tax reforms in the country. Similarly, Amgen announced a 5-year capital investment of approximately US$ 3.5 billion in the U.S. and later in July 2018, it announced a new US$ 300 million plant in Greenwich, Rhode Island campus. Eli Lilly announced an investment of US$ 72.0 million for an insulin manufacturing project in 2018.
What is the Regulatory Impact on India market?
Currently, India is one of the top five global manufacturers of pharmaceutical intermediates. The production of pharmaceutical intermediates has continued to grow with an increasing number of multinational companies in India to meet their pharmaceutical intermediates supply needs. In addition, India has the largest number of United States Food & Drug Administration -approved production companies outside the USA.
Every year Indian companies file significant number of drug master filings (DMF). Moreover, increasing production of APIs has led to increase demand for pharmaceutical intermediates. In India chemical manufacturers have the R&D capabilities and technical expertise to produce high-quality, complex, and niche intermediates. The key drugs driving sales and hence, the production of pharmaceutical intermediates, have been anti-infective and antibiotics, anti-inflammatory drugs, central nervous system drugs, cardiovascular system drugs, anti-diabetics
How is Japan Gaining from Pharma Sector Growth?
Japan is the 3rd largest pharma industry in the world. The Japanese government has gone as far as to increase investment in the generic drug market. According to the International Society for Pharmaceutical Engineering, the use of generic drugs increased to 65.8% in 2017 from 39.9% in 2011.
The total annual pharmaceutical spending accounted for 18.3% of health spending in 2017, as per the Organization for Economic Co-operation and Development (OCED). Moreover, Government of Japan’s national insurance scheme has been favoring growth of the overall pharmaceutical sector. Increase burden of aging population and wide access to healthcare are the chief driving factors of pharmaceutical intermediates market.
How Presence Of Renowned Companies Causing Germany To Surge?
While China and the U.S. will continue leading, growth in Germany is expected to happen at an accelerated pace. As per FMI, presence of pharmaceutical intermediate companies in Germany is more. Some prominent players in pharmaceutical intermediate such as Chiracon GmbH, Midas Pharma GmbH, BASF SE are present in Germany which creates significant revenue. Moreover, large number of domestic players also available in Germany which create surge in pharmaceutical intermediate production in Germany.
What is the Market Share of Bulk Drug Intermediates?
The bulk drug intermediates segment will continue accounting for over 60% the global share among products through the forecast period. According to FMI, the segment is expected to hold a more than 60% of the market, in terms of product type, by the end of 2030. Bulk drug intermediates segment going to show significant growth in India. For promotion of Bulk Drug Parks, PM Narendra Modi has approved schemes to promote Bulk Drug Parks. Government provide financial implication of US$ 409 Mn for next five years For 3 Bulk Drug Parks. Moreover, Bulk drug intermediates are mostly used in drug development process.
Generic Drug Intermediates to Remain Dominant
Generic drug intermediates by category type holds more than 60% of the overall share through the forecast period, generic drug intermediates continue to account for increasing demand. Rising growth of generic drug intermediates in countries such as Japan, China, and India will continue aiding expansion in the segment. In Japan, government is targeting 80% generic penetration by 2020 and start gradual reduction in use of branded products.
Moreover, generic drug manufacturers in India are integral to the expansion of the pharmaceutical industry and hold strong supply chain globally. In addition to this India is the source of sixty thousand generic brands across sixty therapeutic categories and manufactures more than five hundred APIs.
Analgesics to Account for Maximum Application
Accounting for over 30% of the global market, analgesics will account for maximum application of pharmaceutical intermediates through the course of the forecast period. Analgesics are increasingly used for providing short-term or long-term relief for severe pain. Expansion within this category will be driven by the rising incidence of chronic ailments such as cancer, arthritis, cardiovascular diseases, and others.
According to the arthritis.org, arthritis affects at least one in four adults in the U.S. Meanwhile, the WHO says that the prevalence of arthritis varies between 0.3% and 1% in developed countries. With incidence of chronic ailments forecast to rise further, the demand for analgesics is expected to get stronger in the coming years.
CMOs/CROs to Exhibit High Demand
FMI has forecast CMOs/ CROs to account for the leading market share through the course of the forecast period. Growth witnessed in CMOs/ CROs industries in the last few years has been resulting in high demand for pharmaceutical intermediates. Contract research organizations (CROs) are more popular because they offer cost-effective solutions to firms seeking to produce medicines and large markets, alike.
Contract manufacturing organizations (CMOs) serve various organizations within the pharmaceutical industry with contractual services. Rise in automation in the CMO industry to offer more personalized experience has been enabling growth in the segment. For instance,
Competitive Landscape
Some of the leading companies operating in the market are Cambrex Corporation, BASF SE, Aceto Crporation, Interchem, Cambrex Corporation, Arkema Inc. Major Manufacturers are focusing on development of intermediates by offering wide range of pharmaceutical intermediates. Moreover, major players in pharmaceutical intermediates market are focus on enhancing their global and regional presence through acquisition and expansion. For instance, On February 2019, ACETO announced sale of its chemicals business assets to New Mountain Capital for $338 million. On July 2017, Lianhetech announced the acquisition of Fine Industries Limited including its subsidiaries Fine Organics Ltd. and Fine Environmental Services Ltd.
Some of the leading companies operating in the market are:
- Cambrex Corporation
- BASF SE.
- Aceto Crporation
- Interchem.
- Arkema Inc.
- Chiracon GmbH.
- Midas Pharma GmbH.
- Chemcon Specialty Chemical Pvt. Ltd..
- Dextra Laboratories Limited
- Pfizer
- Codexis, Inc
- Sanofi
- Dishman Group
- Dextra Laboratories Limited
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Pharmaceutical Intermediates Market - Scope of the Report
|
Attribute |
Details |
|
Pharmaceutical Intermediates Market - Forecast Period |
2020-2030 |
|
Pharmaceutical Intermediates Market - Historical Data Available for |
2016-2019 |
|
Pharmaceutical Intermediates Market - Market Analysis |
USD Million for value and Units for Volume |
|
Pharmaceutical Intermediates Market - Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Pharmaceutical Intermediates Market - Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
|
Pharmaceutical Intermediates Market - Key Segments Covered |
Product Type, Category, Application, End User and Region |
|
Pharmaceutical Intermediates Market - Key Companies Profiled |
|
|
Pharmaceutical Intermediates Market - Report Coverage |
Market Forecast, company share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Pharmaceutical Intermediates Market - Key Segments
Product:
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
Category:
- Branded Drug Intermediates
- Generic Drug Intermediates
Application:
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
End User:
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa (MEA)
- Oceania
Frequently Asked Questions
China currently leads the global market for pharmaceutical intermediates. Sales in China will be over 40% of total demand throughout the forecast period.
Bulk drug intermediates are highly sought-after in every market. The demand for bulk drug intermediates are expected to remain high in the near future, especially due to growing usage in drug development.
Pharmaceutical intermediates are mostly used in analgesics drug development.
Some of the leading companies offering pharmaceutical intermediates are Cambrex Corporation, BASF SE, Aceto Crporation, Interchem, Arkema Inc., among others.
The World Health Organization has identified chronic disease as one of the major death causing factor around the world. It also estimated that more than 35 million people had died due to chronic disease globally.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Context
4.1. Product Adoption / Usage Analysis
4.2. Promotional Strategies by Key Players
4.3. Regulatory Scenario
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Per Capita Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing prevalence of Chronic Disorders
5.2.2. Increasing Investments in Pharmaceutical Intermediates manufacturing
5.2.3. Growing aging population of the world
5.3. Value Chain
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
6. COVID19 Crisis Impact Analysis
6.1. Current COVID-19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Country
6.5. 2020 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter
6.8. Recovery Scenario - Short term, Midterm and Long Term Impact
7. Global Pharmaceutical Intermediates Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
8.3.1. Chemical Intermediates
8.3.2. Bulk Drug Intermediates
8.3.2.1. Chiral Intermediates
8.3.2.2. Achiral Intermediates
8.3.3. Custom Intermediates
8.4. Market Attractiveness Analysis By Product Type
9. Global Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030, by Category
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Category, 2020-2030
9.3.1. Branded Drug Intermediates
9.3.2. Generic Drug Intermediates
9.4. Market Attractiveness Analysis By Category
10. Global Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Category, 2020-2030
10.3.1. Analgesics
10.3.2. Anti-inflammatory Drug
10.3.3. Cardiovascular Drugs
10.3.4. Anti-diabetic Drugs
10.3.5. Antimicrobial Drugs
10.3.6. Anti-cancer Drugs
10.3.7. Others
10.4. Market Attractiveness Analysis By Category
11. Global Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
11.3.1. Biotech and Pharma Companies
11.3.2. Research Laboratory
11.3.3. CMOs/CROs
11.4. Market Attractiveness Analysis By End User
12. Global Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product Type
13.3.3. Category
13.3.4. Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product Type
14.3.3. Category
14.3.4. Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product Type
15.3.3. Category
15.3.4. Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product Type
16.3.3. Category
16.3.4. Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product Type
17.3.3. Category
17.3.4. Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product Type
18.3.3. Category
18.3.4. Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Product Type
19.3.3. Category
19.3.4. Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Key and Emerging Countries Pharmaceutical Intermediates Market Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. U.S. Pharmaceutical Intermediates Market Analysis
20.2.1. By Product Type
20.2.2. Category
20.2.3. Application
20.2.4. By End User
20.3. Canada Pharmaceutical Intermediates Market Analysis
20.3.1. By Product Type
20.3.2. Category
20.3.3. Application
20.3.4. By End User
20.4. Mexico Pharmaceutical Intermediates Market Analysis
20.4.1. By Product Type
20.4.2. Category
20.4.3. Application
20.4.4. By End User
20.5. Brazil Pharmaceutical Intermediates Market Analysis
20.5.1. By Product Type
20.5.2. Category
20.5.3. Application
20.5.4. By End User
20.6. U.K. Pharmaceutical Intermediates Market Analysis
20.6.1. By Product Type
20.6.2. Category
20.6.3. Application
20.6.4. By End User
20.7. Germany Pharmaceutical Intermediates Market Analysis
20.7.1. By Product Type
20.7.2. Category
20.7.3. Application
20.7.4. By End User
20.8. France Pharmaceutical Intermediates Market Analysis
20.8.1. By Product Type
20.8.2. Category
20.8.3. Application
20.8.4. By End User
20.9. Italy Pharmaceutical Intermediates Market Analysis
20.9.1. By Product Type
20.9.2. Category
20.9.3. Application
20.9.4. By End User
20.10. BENELUX Pharmaceutical Intermediates Market Analysis
20.10.1. By Product Type
20.10.2. Category
20.10.3. Application
20.10.4. By End User
20.11. Russia Pharmaceutical Intermediates Market Analysis
20.11.1. By Product Type
20.11.2. Category
20.11.3. Application
20.11.4. By End User
20.12. China Pharmaceutical Intermediates Market Analysis
20.12.1. By Product Type
20.12.2. Category
20.12.3. Application
20.12.4. By End User
20.13. Japan Pharmaceutical Intermediates Market Analysis
20.13.1. By Product Type
20.13.2. Category
20.13.3. Application
20.13.4. By End User
20.14. South Korea Pharmaceutical Intermediates Market Analysis
20.14.1. By Product Type
20.14.2. Category
20.14.3. Application
20.14.4. By End User
20.15. India Pharmaceutical Intermediates Market Analysis
20.15.1. By Product Type
20.15.2. Category
20.15.3. Application
20.15.4. By End User
20.16. Australia Pharmaceutical Intermediates Market Analysis
20.16.1. By Product Type
20.16.2. Category
20.16.3. Application
20.16.4. By End User
20.17. New Zealand Pharmaceutical Intermediates Market Analysis
20.17.1. By Product Type
20.17.2. Category
20.17.3. Application
20.17.4. By End User
20.18. GCC Countries Pharmaceutical Intermediates Market Analysis
20.18.1. By Product Type
20.18.2. Category
20.18.3. Application
20.18.4. By End User
20.19. Turkey Pharmaceutical Intermediates Market Analysis
20.19.1. By Product Type
20.19.2. Category
20.19.3. Application
20.19.4. By End User
20.20. South Africa Pharmaceutical Intermediates Market Analysis
20.20.1. By Product Type
20.20.2. Category
20.20.3. Application
20.20.4. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1. By Regional footprint of Players
21.4.2. Product foot print by Players
21.4.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Deep Dive
22.2.1. Chiracon GmbH
22.2.1.1. Overview
22.2.1.2. Product Portfolio
22.2.1.3. Profitability by Market Segments (Product/End User/Region)
22.2.1.4. Sales Footprint
22.2.1.5. Strategy Overview
22.2.1.5.1. Marketing Strategy
22.2.1.5.2. Product Strategy
22.2.1.5.3. Channel Strategy
22.2.2. Aceto Corporation
22.2.2.1. Overview
22.2.2.2. Product Portfolio
22.2.2.3. Profitability by Market Segments (Product/End User/Region)
22.2.2.4. Sales Footprint
22.2.2.5. Strategy Overview
22.2.2.5.1. Marketing Strategy
22.2.2.5.2. Product Strategy
22.2.2.5.3. Channel Strategy
22.2.3. Midas Pharma GmbH
22.2.3.1. Overview
22.2.3.2. Product Portfolio
22.2.3.3. Profitability by Market Segments (Product/End User/Region)
22.2.3.4. Sales Footprint
22.2.3.5. Strategy Overview
22.2.3.5.1. Marketing Strategy
22.2.3.5.2. Product Strategy
22.2.3.5.3. Channel Strategy
22.2.4. Codexis
22.2.4.1. Overview
22.2.4.2. Product Portfolio
22.2.4.3. Profitability by Market Segments (Product/End User/Region)
22.2.4.4. Sales Footprint
22.2.4.5. Strategy Overview
22.2.4.5.1. Marketing Strategy
22.2.4.5.2. Product Strategy
22.2.4.5.3. Channel Strategy
22.2.5. Lianhe Chemical Technology Co., Ltd
22.2.5.1. Overview
22.2.5.2. Product Portfolio
22.2.5.3. Profitability by Market Segments (Product/End User/Region)
22.2.5.4. Sales Footprint
22.2.5.5. Strategy Overview
22.2.5.5.1. Marketing Strategy
22.2.5.5.2. Product Strategy
22.2.5.5.3. Channel Strategy
22.2.6. BASF SE
22.2.6.1. Overview
22.2.6.2. Product Portfolio
22.2.6.3. Profitability by Market Segments (Product/End User/Region)
22.2.6.4. Sales Footprint
22.2.6.5. Strategy Overview
22.2.6.5.1. Marketing Strategy
22.2.6.5.2. Product Strategy
22.2.6.5.3. Channel Strategy
22.2.7. Vertellus Holdings LLC
22.2.7.1. Overview
22.2.7.2. Product Portfolio
22.2.7.3. Profitability by Market Segments (Product/End User/Region)
22.2.7.4. Sales Footprint
22.2.7.5. Strategy Overview
22.2.7.5.1. Marketing Strategy
22.2.7.5.2. Product Strategy
22.2.7.5.3. Channel Strategy
22.2.8. Sanofi S.A.
22.2.8.1. Overview
22.2.8.2. Product Portfolio
22.2.8.3. Profitability by Market Segments (Product/End User/Region)
22.2.8.4. Sales Footprint
22.2.8.5. Strategy Overview
22.2.8.5.1. Marketing Strategy
22.2.8.5.2. Product Strategy
22.2.8.5.3. Channel Strategy
22.2.9. A. R. Life Sciences Private Limited
22.2.9.1. Overview
22.2.9.2. Product Portfolio
22.2.9.3. Profitability by Market Segments (Product/End User/Region)
22.2.9.4. Sales Footprint
22.2.9.5. Strategy Overview
22.2.9.5.1. Marketing Strategy
22.2.9.5.2. Product Strategy
22.2.9.5.3. Channel Strategy
22.2.10. Dishman Group
22.2.10.1. Overview
22.2.10.2. Product Portfolio
22.2.10.3. Profitability by Market Segments (Product/End User/Region)
22.2.10.4. Sales Footprint
22.2.10.5. Strategy Overview
22.2.10.5.1. Marketing Strategy
22.2.10.5.2. Product Strategy
22.2.10.5.3. Channel Strategy
22.2.11. Chemcon Speciality Chemicals Pvt. Ltd
22.2.11.1. Overview
22.2.11.2. Product Portfolio
22.2.11.3. Profitability by Market Segments (Product/End User/Region)
22.2.11.4. Sales Footprint
22.2.11.5. Strategy Overview
22.2.11.5.1. Marketing Strategy
22.2.11.5.2. Product Strategy
22.2.11.5.3. Channel Strategy
22.2.12. Dextra Laboratories Ltd
22.2.12.1. Overview
22.2.12.2. Product Portfolio
22.2.12.3. Profitability by Market Segments (Product/End User/Region)
22.2.12.4. Sales Footprint
22.2.12.5. Strategy Overview
22.2.12.5.1. Marketing Strategy
22.2.12.5.2. Product Strategy
22.2.12.5.3. Channel Strategy
22.2.13. ZCL Chemicals Ltd
22.2.13.1. Overview
22.2.13.2. Product Portfolio
22.2.13.3. Profitability by Market Segments (Product/End User/Region)
22.2.13.4. Sales Footprint
22.2.13.5. Strategy Overview
22.2.13.5.1. Marketing Strategy
22.2.13.5.2. Product Strategy
22.2.13.5.3. Channel Strategy
22.2.14. Eastar Industries
22.2.14.1. Overview
22.2.14.2. Product Portfolio
22.2.14.3. Profitability by Market Segments (Product/End User/Region)
22.2.14.4. Sales Footprint
22.2.14.5. Strategy Overview
22.2.14.5.1. Marketing Strategy
22.2.14.5.2. Product Strategy
22.2.14.5.3. Channel Strategy
22.2.15. Pfizer Inc.
22.2.15.1. Overview
22.2.15.2. Product Portfolio
22.2.15.3. Profitability by Market Segments (Product/End User/Region)
22.2.15.4. Sales Footprint
22.2.15.5. Strategy Overview
22.2.15.5.1. Marketing Strategy
22.2.15.5.2. Product Strategy
22.2.15.5.3. Channel Strategy
22.2.16. Bristol-Myers Squibb Company
22.2.16.1. Overview
22.2.16.2. Product Portfolio
22.2.16.3. Profitability by Market Segments (Product/End User/Region)
22.2.16.4. Sales Footprint
22.2.16.5. Strategy Overview
22.2.16.5.1. Marketing Strategy
22.2.16.5.2. Product Strategy
22.2.16.5.3. Channel Strategy
22.2.17. Arkema Group
22.2.17.1. Overview
22.2.17.2. Product Portfolio
22.2.17.3. Profitability by Market Segments (Product/End User/Region)
22.2.17.4. Sales Footprint
22.2.17.5. Strategy Overview
22.2.17.5.1. Marketing Strategy
22.2.17.5.2. Product Strategy
22.2.17.5.3. Channel Strategy
22.2.18. Interchem
22.2.18.1. Overview
22.2.18.2. Product Portfolio
22.2.18.3. Profitability by Market Segments (Product/End User/Region)
22.2.18.4. Sales Footprint
22.2.18.5. Strategy Overview
22.2.18.5.1. Marketing Strategy
22.2.18.5.2. Product Strategy
22.2.18.5.3. Channel Strategy
22.2.19. Cambrex Corporation
22.2.19.1. Overview
22.2.19.2. Product Portfolio
22.2.19.3. Profitability by Market Segments (Product/End User/Region)
22.2.19.4. Sales Footprint
22.2.19.5. Strategy Overview
22.2.19.5.1. Marketing Strategy
22.2.19.5.2. Product Strategy
22.2.19.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 04: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 05: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 06: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 07: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 08: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 09: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 10: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 11: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 12: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 13: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 14: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 15: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 16: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 17: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 18: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 19: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 20: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 21: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 22: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 23: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 24: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 25: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 26: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 27: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 28: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 29: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 30: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 31: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 32: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 33: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 34: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 35: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 36: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 37: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 38: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 39: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 40: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Table 41: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 42: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Pharmaceutical Intermediates Market Share, By Product Type (2020)
Figure 02: Global Pharmaceutical Intermediates Market Share, By Category (2020)
Figure 03: Global Pharmaceutical Intermediates Market Share, By Application (2020)
Figure 04: Global Pharmaceutical Intermediates Market Share, By End User (2020)
Figure 05: Global Pharmaceutical Intermediates Market Share, By Region (2020)
Figure 06: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 07: Global Pharmaceutical Intermediates Historical Market Size and Y-o-Y, 2015-2019
Figure 08: Global Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020–2030
Figure 09: Global Pharmaceutical Intermediates Market Absolute $ Opportunity, 2015–2030
Figure 10: Global Pharmaceutical Intermediates Market Analysis by Product Type –2020 & 2030
Figure 11: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 12: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Figure 13: Global Pharmaceutical Intermediates Market Analysis by Category –2020 & 2030
Figure 14: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 15: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Category
Figure 16: Global Pharmaceutical Intermediates Market Analysis by Application –2020 & 2030
Figure 17: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 18: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Figure 19: Global Pharmaceutical Intermediates Market Analysis by End User –2020 & 2030
Figure 20: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 21: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Figure 22: Global Pharmaceutical Intermediates Market Analysis by Region –2020 & 2030
Figure 23: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Region, 2020 – 2030
Figure 24: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Figure 25: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2015–2019
Figure 26: North America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020 – 2030
Figure 27: North America Pharmaceutical Intermediates Market Analysis by Country –2020 & 2030
Figure 28: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2020 – 2030
Figure 29: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2020 – 2030
Figure 30: North America Pharmaceutical Intermediates Market Analysis by Product Type–2020 & 2030
Figure 31: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 32: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2020 – 2030
Figure 33: North America Pharmaceutical Intermediates Market Analysis by Category – 2020 & 2030
Figure 34: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 35: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2020 – 2030
Figure 36: North America Pharmaceutical Intermediates Market Analysis by Application – 2020 & 2030
Figure 37: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 38: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2020 – 2030
Figure 39: North America Pharmaceutical Intermediates Market Analysis by End User – 2020 & 2030
Figure 40: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 41: North America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2020 – 2030
Figure 42: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2015–2019
Figure 43: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020 – 2030
Figure 44: Latin America Pharmaceutical Intermediates Market Analysis by Country –2020 & 2030
Figure 45: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2020 – 2030
Figure 46: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2020 – 2030
Figure 47: Latin America Pharmaceutical Intermediates Market Analysis by Product Type–2020 & 2030
Figure 48: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 49: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2020 – 2030
Figure 50: Latin America Pharmaceutical Intermediates Market Analysis by Category – 2020 & 2030
Figure 51: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 52: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2020 – 2030
Figure 53: Latin America Pharmaceutical Intermediates Market Analysis by Application – 2020 & 2030
Figure 54: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 55: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2020 – 2030
Figure 56: Latin America Pharmaceutical Intermediates Market Analysis by End User – 2020 & 2030
Figure 57: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 58: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2020 – 2030
Figure 59: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2015–2019
Figure 60: Europe Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020 – 2030
Figure 61: Europe Pharmaceutical Intermediates Market Analysis by Country –2020 & 2030
Figure 62: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2020 – 2030
Figure 63: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2020 – 2030
Figure 64: Europe Pharmaceutical Intermediates Market Analysis by Product Type–2020 & 2030
Figure 65: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 66: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2020 – 2030
Figure 67: Europe Pharmaceutical Intermediates Market Analysis by Category – 2020 & 2030
Figure 68: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 69: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2020 – 2030
Figure 70: Europe Pharmaceutical Intermediates Market Analysis by Application – 2020 & 2030
Figure 71: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 72: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2020 – 2030
Figure 73: Europe Pharmaceutical Intermediates Market Analysis by End User – 2020 & 2030
Figure 74: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 75: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2020 – 2030
Figure 76: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2015–2019
Figure 77: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020 – 2030
Figure 78: South Asia Pharmaceutical Intermediates Market Analysis by Country – 2020 & 2030
Figure 79: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2020 – 2030
Figure 80: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2020 – 2030
Figure 81: South Asia Pharmaceutical Intermediates Market Analysis by Product Type–2020 & 2030
Figure 82: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 83: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2020 – 2030
Figure 84: South Asia Pharmaceutical Intermediates Market Analysis by Category – 2020 & 2030
Figure 85: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 86: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2020 – 2030
Figure 87: South Asia Pharmaceutical Intermediates Market Analysis by Application – 2020 & 2030
Figure 88: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 89: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2020 – 2030
Figure 90: South Asia Pharmaceutical Intermediates Market Analysis by End User – 2020 & 2030
Figure 91: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 92: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2020 – 2030
Figure 93: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2015–2019
Figure 94: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020 – 2030
Figure 95: East Asia Pharmaceutical Intermediates Market Analysis by Country–2020 & 2030
Figure 96: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2020 – 2030
Figure 97: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2020 – 2030
Figure 98: East Asia Pharmaceutical Intermediates Market Analysis by Product Type–2020 & 2030
Figure 99: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 100: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2020 – 2030
Figure 101: East Asia Pharmaceutical Intermediates Market Analysis by Category – 2020 & 2030
Figure 102: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 103: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2020 – 2030
Figure 104: East Asia Pharmaceutical Intermediates Market Analysis by Application – 2020 & 2030
Figure 105: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 106: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2020 – 2030
Figure 107: East Asia Pharmaceutical Intermediates Market Analysis by End User – 2020 & 2030
Figure 108: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 109: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2020 – 2030
Figure 110: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2015–2019
Figure 111: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020 – 2030
Figure 112: Oceania Pharmaceutical Intermediates Market Analysis by Country –2020 & 2030
Figure 113: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2020 – 2030
Figure 114: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2020 – 2030
Figure 115: Oceania Pharmaceutical Intermediates Market Analysis by Product Type–2020 & 2030
Figure 116: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 117: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2020 – 2030
Figure 118: Oceania Pharmaceutical Intermediates Market Analysis by Category – 2020 & 2030
Figure 119: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 120: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2020 – 2030
Figure 121: Oceania Pharmaceutical Intermediates Market Analysis by Application – 2020 & 2030
Figure 122: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 123: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2020 – 2030
Figure 124: Oceania Pharmaceutical Intermediates Market Analysis by End User – 2020 & 2030
Figure 125: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 126: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2020 – 2030
Figure 127: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2015–2019
Figure 128: MEA Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2020 – 2030
Figure 129: MEA Pharmaceutical Intermediates Market Analysis by Country – 2020 & 2030
Figure 130: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2020 – 2030
Figure 131: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2020 – 2030
Figure 132: MEA Pharmaceutical Intermediates Market Analysis by Product Type–2020 & 2030
Figure 133: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2020 – 2030
Figure 134: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2020 – 2030
Figure 135: MEA Pharmaceutical Intermediates Market Analysis by Category – 2020 & 2030
Figure 136: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2020 – 2030
Figure 137: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2020 – 2030
Figure 138: MEA Pharmaceutical Intermediates Market Analysis by Application – 2020 & 2030
Figure 139: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2020 – 2030
Figure 140: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2020 – 2030
Figure 141: MEA Pharmaceutical Intermediates Market Analysis by End User – 2020 & 2030
Figure 142: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2020 – 2030
Figure 143: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2020 – 2030
Figure 144: U.S Market Value Proportion Analysis, 2020
Figure 145: U.S. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 146: U.S. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 147: U.S. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 148: U.S Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 149: Canada Market Value Proportion Analysis, 2020
Figure 150: Canada. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 151: Canada. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 152: Canada. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 153: Canada Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 154: Mexico Market Value Proportion Analysis, 2020
Figure 155: Mexico. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 156: Mexico. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 157: Mexico. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 158: Mexico Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 159: Brazil Market Value Proportion Analysis, 2020
Figure 160: Brazil. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 161: Brazil. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 162: Brazil. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 163: Brazil Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 164: U.K. Market Value Proportion Analysis, 2020
Figure 165: U.K.. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 166: U.K.. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 167: U.K.. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 168: U.K. Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 169: Germany Market Value Proportion Analysis, 2020
Figure 170: Germany. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 171: Germany. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 172: Germany. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 173: Germany Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 174: France Market Value Proportion Analysis, 2020
Figure 175: France. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 176: France. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 177: France. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 178: France Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 179: Italy Market Value Proportion Analysis, 2020
Figure 180: Italy. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 181: Italy. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 182: Italy. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 183: Italy Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 184: BENELUX Market Value Proportion Analysis, 2020
Figure 185: BENELUX. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 186: BENELUX. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 187: BENELUX. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 188: BENELUX Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 189: Russia Market Value Proportion Analysis, 2020
Figure 190: Russia. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 191: Russia. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 192: Russia. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 193: Russia Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 194: China Market Value Proportion Analysis, 2020
Figure 195: China. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 196: China. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 197: China. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 198: China Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 199: Japan Market Value Proportion Analysis, 2020
Figure 200: Japan. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 201: Japan. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 202: Japan. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 203: Japan Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 204: South Korea Market Value Proportion Analysis, 2020
Figure 205: South Korea. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 206: South Korea. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 207: South Korea. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 208: South Korea Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 209: India Market Value Proportion Analysis, 2020
Figure 210: India. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 211: India. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 212: India. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 213: India Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 214: Australia Market Value Proportion Analysis, 2020
Figure 215: Australia. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 216: Australia. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 217: Australia. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 218: Australia Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 219: New Zealand Market Value Proportion Analysis, 2020
Figure 220: New Zealand. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 221: New Zealand. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 222: New Zealand. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 223: New Zealand Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 224: GCC Countries Market Value Proportion Analysis, 2020
Figure 225: GCC Countries Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 226: GCC Countries Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 227: GCC Countries Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 228: GCC Countries Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 229: South Africa Market Value Proportion Analysis, 2020
Figure 230: South Africa. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 231: South Africa. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 232: South Africa. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 233: South Africa Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Figure 234: Turkey Market Value Proportion Analysis, 2020
Figure 235: Turkey. Pharmaceutical Intermediates Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 236: Turkey. Pharmaceutical Intermediates Market Share Analysis (%) By Category, 2020 & 2030
Figure 237: Turkey. Pharmaceutical Intermediates Market Share Analysis (%) By End User, 2020 & 2030
Figure 238: Turkey Pharmaceutical Intermediates Market Share Analysis (%) By Application, 2020 & 2030
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
